Clinical Trial Update: The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates the effect of preoperative docetaxel, cisplatin, and capecitabine on serum RUNX3 hypermethylation in patients with gastric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lower Esophagus
• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (Xeloda) (Capecitabine)
• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN